VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 143 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $7,069,000 | -50.6% | 384,160 | -29.8% | 0.01% | -54.5% |
| Q4 2018 | $14,308,000 | -57.1% | 547,557 | -62.3% | 0.01% | 0.0% |
| Q3 2018 | $33,370,000 | +155.6% | 1,454,046 | +112.2% | 0.01% | +22.2% |
| Q2 2018 | $13,056,000 | +50.1% | 685,336 | +32.8% | 0.01% | +50.0% |
| Q1 2018 | $8,696,000 | +28.1% | 516,082 | +15.6% | 0.01% | +50.0% |
| Q4 2017 | $6,787,000 | -10.8% | 446,482 | +5.1% | 0.00% | -20.0% |
| Q3 2017 | $7,605,000 | +50.7% | 424,887 | +37.2% | 0.01% | +25.0% |
| Q2 2017 | $5,048,000 | -11.8% | 309,682 | -24.3% | 0.00% | 0.0% |
| Q1 2017 | $5,725,000 | -7.8% | 408,952 | +5.1% | 0.00% | -20.0% |
| Q4 2016 | $6,209,000 | -1.5% | 389,278 | +2.7% | 0.01% | +25.0% |
| Q3 2016 | $6,306,000 | +88.6% | 378,964 | +26.8% | 0.00% | +33.3% |
| Q2 2016 | $3,343,000 | +89.3% | 298,773 | +41.4% | 0.00% | +200.0% |
| Q1 2016 | $1,766,000 | +40.9% | 211,246 | +57.0% | 0.00% | 0.0% |
| Q4 2015 | $1,253,000 | -17.5% | 134,546 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $1,518,000 | -7.3% | 134,546 | +4.2% | 0.00% | 0.0% |
| Q2 2015 | $1,638,000 | +37.3% | 129,115 | +0.7% | 0.00% | 0.0% |
| Q1 2015 | $1,193,000 | -83.5% | 128,249 | -74.5% | 0.00% | -80.0% |
| Q4 2014 | $7,213,000 | +36.9% | 503,695 | -0.8% | 0.01% | +25.0% |
| Q3 2014 | $5,268,000 | -39.2% | 507,502 | -5.2% | 0.00% | -33.3% |
| Q2 2014 | $8,661,000 | +23.0% | 535,303 | +23.5% | 0.01% | +20.0% |
| Q1 2014 | $7,041,000 | +26.3% | 433,278 | -3.6% | 0.01% | +25.0% |
| Q4 2013 | $5,577,000 | +4.0% | 449,394 | -8.1% | 0.00% | 0.0% |
| Q3 2013 | $5,362,000 | +38.1% | 488,790 | +1.7% | 0.00% | +33.3% |
| Q2 2013 | $3,882,000 | – | 480,429 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
| Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
| Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
| GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
| Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
| UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
| Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
| Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
| 361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |